Member Info for JohnLewis79

Wonder whether our mrkt cap is worth more than the the bods annual salaries? Leaving the SM our value was just over £500K and outside of going to the knackers yard must rate as one of the biggest destructions of capital ever (funds poured in c £75m+) for zero gain in value. Mind you our balance sheet showed shareholder funds just short of £7m or c.5 pps made up mostly of non current assets (goodwill, patents etc..). That's a large discrepancy but as we know the Sphere market never focussed on the fundamentals preferring to see the lack of progress as a fatal flaw despite the obvious improvements (CE, production, distribution & sales). I never bought into that doomsday scenario believing that value will out eventually. Well, eventually is now upon us!

Thanx for that Del but I'm not sure I'm any the wiser.

Anyone know what a Senior Data & Analysis Engineer does? Some sort of computer software geek I assume.

When lactate is added that will be 14 analyte panels P can perform. Glucose alone improved the space fourfold. With lactate added this will expand the addressable Healthcare parameters once more. For instance patient monitoring in other parts of the hospital such as care for the elderly, chronic diseases and sepsis. These combined will boost P's use dramatically as these in total are much larger than Critical Care arena. Pretty sure this is a matter of some urgency for Sphere, increasing the volume of patient connections will boost Proximas leverage in Healthcare throughout hospital departments. For all we know this might already be up and running.

Newsflow is the lifeblood of most Aim Co shares. I would rate Ideagen by far and away the best Co in this regard. I have been in a few whereby 2-4 updates pa is considered good!

Bloody hell!!......

Not sure about that....we (Wales) knock on open doors unfortunately Palace by pass them! With all your stocks rugs.....check you haven't missed JOG. Heh heh heh!!

Wonder how much of the 106.3m CPS was taken up as W & E did not participate? An extra £3m not to be sniffed at as this could be nearly 12 months funding of costs. If OCD are still with us would they have invested? My bet is no. So if W can get monthly outgoings (I'm factoring in no incomings) to £250-300k pm or less over (40 headcount) with very careful cash conservation we might last until end 2018, then extending as revenues start coming in assuming they are still interested in supplying hospitals here and abroad.

From most sources I've read Idea own this space and as Pilot Bill says it's an expanding one. I'm not as up to speed as I should be on this sector as I'm more involved elsewhere but I consider their track record since the IPO to be very very good and was an initial attraction for me. (Check the graphs!). They are also selling into a wide and diverse sectors of industry which looks to become more and more important in years to come. They say they are the Global leader in the GRC sector. As to further acquisitions (4 in '17) they do seem to be of the sub £5m variety and Idea could well have finished their buying spree of the last few years concentrating on building their customer base (150+ in'17). Integrating acquisitions are going well and increasing FCF is hugely important at this stage of Ideas development. Worth noting the sector is growing at c.13% pa and is worth $4bn annually not to mention the Co is debt free and pays a small dividend. Downside might be expanding too fast into other areas. I see no signs of that happening yet. So far Ideas recurring rev's and built in maintenance contracts are in the 90% retention rate and they can upgrade the service to their customers. For such a small Co they are doing remarkably well and the outlook for the business is robust

Not for me it weren't!

Woodford & the Wales LS Fund own 77%. If as Del suggests OCD are still on the register with c 3% then pis & others hold c 90m or 20% pre close today of second/delayed CPS offering.

Sorry the motif post is on Advfn Genel board....don't know why?

You might like to check Motif Bio post on advfn site....

Me too! Wales 11/8f...Ire c.2's.

One of Britain's hottest biotechnology companies has said it expects to turn a profit within three years. The co valued at £1.2bn is among a swathe of UK innovators which while loss-making are tipped to become titans of the future..Their sky high valuations often pay no heed to revenue, instead focussing on the value of their scientific assets, er wot?....not in our bloody case mate, ours are worthless for chrissssakes! Oh well...Ox Nan lost £59m on rev of £4.5m last year making ON 1000x more valuable than Sphere. Good for them.

Cut from the ST article today.... The trouble with private companies is that detailed numbers are not given out. However, investors such as W are likely to be allowed a much closer look, (well obviously he owns Sphere... my words) ....A spokesman said W was not responsible for the pricing of unquoted companies in his portfolio. "Capita (the fund administration service) provides independent oversight to pricing" he said. Others in the investment community who do not subscribe to Woodford's approach suggest that the valuations of private companies can be pumped up by a small nos of investors. "If Oxford Nanopore were to float wirh a $1bn valuation you have got to raise at least £200m" said one fund manager. "That's quite a chunk of change. You get the same group of people putting money in after each other." Incidentally 44% of his PCT is in private companies. Woodford is still making new investments but some have said they will be less frequent. He can raise cash by selling down his stake in quoted companies but is more likely to pick his winners carefully. "As a new Co it's going to be harder to get into his Patient Capital fund," said one investor.

Morning pk...can't complain though Sphere as a private entity now, my lender is understandably nervous about being repaid heh heh heh! Forces me to have a more responsible attitude re discretionary spend....ie the ponies and the vino. Typically I had a 4/1& 11/8 win win win double come up and not a red cent on it! Grrrr!! Are you still invested in Sphere? Be interesting to see what prices are offered when and if the platform is set up. As to the technicalities I've no idea. Does one buy/sell through your broker? The paperwork might be a hassle, how would you transfer your stock if in nominee form? Guess this is being sorted out now. Am still out of the market 'cept here and no desire to re-enter the fray. A couple of stocks I identified long ago have done very well (Gfinity & Ideagen) both up 50%.. but I couldn't force myself to sell Sphere & buy in......idiot! Very much a wait and see now as Woodford owns the company, we can only hope he will do right by us. Perhaps Sphere will be the agent for change to his reputation? A big winner here when most everybody has deserted the company would signal that if you focus on the fundamentals and not look at the scoreboard every five mins you will be rewarded in time. I'm hoping at the P5 stage, that's the auto version of P and 3 or more years of sales & data we will be worth a lot more than current to a Co that can take Sphere to the next stage.

Morning Del..Right kinda reassuring that Ortho are still on the register. I made it c.302m shares outstanding with others (inc pis) holding c.57m or 23%. Whatever good enough for our purposes. Not sure why they would extend the CPS to the 9th unless to help a buyer. Hope it's picked up as the extra £3m will push back the next funding round. If we get the £8m and a 40% reduction in spend we should be able to carry on for around another 24- 30 months enough to get us to the 510k and the automated version. After that it's in the lap of the Gods...

At a guess pis now hold c.5x the % of Sphere as a private co than when we were publicly listed. Quite the opposite of what Woodford thought I imagine. That shows to me pis the 'trousering' dealt us by the market was overdone and investors took advantage of the silly prices offered. Most of us think there is value in Proxima (broader applications) at least in excess of £1.2m at last quoted price. What the avc is of most pis I've no idea but at a guess I'd say between 1-5 ish. Some lucky ones could be below 1p. Whatever be interesting to see what the bid/offers are (there will be buyers) when it's up & running. Sub 1 will probably take 1. Personally I'd be a buyer (if I had any spare) up to 2.822 for starters. There is still the matter of the second investment round of 106.3m CPS shares to be concluded on 9/10 which W&E are not partaking in. Should the take up be negligible then these may be cancelled or go into treasury. Whether iis would buy these and keep under the 3% (if that applies in a private co?) not sure. Suspect no as they have washed their hands of Sphere. Surprised that Ortho baled out, Winterflood was always a loose holder imo. Oh well more for Mr W.

Only two iis left now on the register. Woodford has 184.3m (58%) & Wales life sciences 60.4m (19.0%). The rearguard hold c.56m (23%).